My lead story for the latest issue of science and technology magazine Shaastra is on the potential of exhaled breath in the early detection of killer diseases and to aid precision medicine. You can access it here. I interviewed researchers from India, China, Israel and the US and was amazed at how far the science … Continue reading The promise and perils of exhaled breath for early diagnosis and precision medicine
Tag: india medical devices
Start-up interest gives boost to development of #point-of-care solutions #medtech
The pandemic has underscored the need for rapid, accurate and affordable screening and diagnostic tools that are as close to the patient as possible. In the latest issue of Shaastra, I have profiled a clutch of companies that are using a wide range of technologies to come up with solutions. You can read the story … Continue reading Start-up interest gives boost to development of #point-of-care solutions #medtech
Stent price control: 5 reasons why ‘high-end stent’ companies might still hope
As the National Pharmaceutical Pricing Authority (NPPA) gets down to revisiting the prices of stents and discussing their makers' grievances in February, here are five reasons why multinational stent companies selling relatively high-end products can still hope. 'All stents made equal' argument reopened to debate? According to a Mint newspaper report, the NPPA requested a … Continue reading Stent price control: 5 reasons why ‘high-end stent’ companies might still hope
Is self-regulation in #medtech doomed to fail?
The offer by needle and syringe manufacturers to voluntarily cap trade margins at 75 per cent after meeting with the National Pharmaceutical Pricing Authority apparently validates the view that without the actionable threat of price control, the healthcare sector cannot be trusted to self-regulate. “The NPPA advised manufacturers to consider regulating price themselves; otherwise, the … Continue reading Is self-regulation in #medtech doomed to fail?
Thermometers, BP monitors and other vital stuff that India DOES NOT regulate #MedTech #safety
The Indian medical devices sector has lately been in the news for the government's decision to liberate foreign direct investment controls on it. There is also some movement on the regulatory front with a decision to set up government-recognised medical device testing laboratories in the country. Apothecurry's guest columnist Dr Ravindra Ghooi revisits the one … Continue reading Thermometers, BP monitors and other vital stuff that India DOES NOT regulate #MedTech #safety
#MedicalDevice pricing in India:”Don’t use a shotgun to kill an ant,”says industry veteran
Late last month, the Maharastra Food & Drug Administration wrote to the National Pharmaceutical Pricing Authority (NPPA) to include medical devices in the Drug Prices Control Order (DPCO) which gives the NPPA its power to fix drug prices. Since the NPPA has been on overdrive, recently adding 108 drug formulations to the list of 348 … Continue reading #MedicalDevice pricing in India:”Don’t use a shotgun to kill an ant,”says industry veteran
Sushrut’s sale to Smith & Nephew : what it says, and what it doesn’t
On May 2, UK-based trauma care products company Smith & Nephew said it would acquire Pune-based Sushrut Surgicals, a homegrown closely-held maker of orthopaedic implants such as bone plates and screws used to correct fractures and deformities, for an undisclosed sum, from the Pitre family. The move took me by surprise. After all, Ajay Pitre, … Continue reading Sushrut’s sale to Smith & Nephew : what it says, and what it doesn’t
Medical technology in India: Is the worm turning?
A recent edition of TED Talks featured Myshkin Ingawale a co-founder of Mumbai-based Biosense which has invented a needle-free, handheld haemoglobin measuring device. This is big for a country where anaemia or low haemoglobin count is the leading cause of maternal mortality even though iron supplements are cheaply and plentifully available. Many of these deaths … Continue reading Medical technology in India: Is the worm turning?
Apothecurry 